Phase 3 KONFIDENT Trial of Oral Sebetralstat for Treatment of Hereditary Angioedema Attacks: Analysis of the European and US Patient Subgroups

Zanichelli A, Aygören-Pürsün E, Bernstein JA, Farkas H, Lumry WR, Maurer M, Riedl MA, Hao J, Smith MD, Audhya PK, Yea C, Cohn DM

ACARE Global Angioedema Forum 2024 (GAF)

Impact of Oral Sebetralstat on Anxiety Associated with Hereditary Angioedema Attacks in the Phase 3 KONFIDENT Trial

Maurer M, Cohn DM, Bernstein JA, Farkas H, Lumry WR, Riedl MA, Zanichelli A, Hao J, Smith MD, PK Audhya, Yea CM, Aygören-Pürsün E

ACARE Global Angioedema Forum 2024 (GAF)

Patient-Reported Benefits of Early On-demand Treatment of HAE Attacks

Guilarte M, Longhurst H, van Kooten S, Malloy N, Heckmann M, Busse P

ACARE Global Angioedema Forum 2024 (GAF)

Advent of oral medications for the treatment of hereditary angioedema

Valerieva A, Caballero T, Magerl M, Frade JP, Audhya PK, Craig PK

Clinical and Translational Allergy

Delayed On-demand Treatment of Hereditary Angioedema Attacks and Associated Barriers Reported by Italian Patients

Cancian M

Bradykinin Symposium 2024

A Specific, Sensitivity Assay Measuring Patient Sample Plasma Kallikrein Activity

Lee D

Bradykinin Symposium 2024

Pooled Sebetralstat Placebo-controlled Safety for On-demand Treatment of Hereditary Angioedema (Oral Presentation)

Aygören-Pürsün E

Bradykinin Symposium 2024

Pooled Sebetralstat Placebo-controlled Efficacy for On-demand Treatment of Hereditary Angioedema (Poster Presentation)

Aygören-Pürsün E

Bradykinin Symposium 2024

Closing Gaps in Hereditary Angioedema Management: Addressing Delays in On-Demand Treatment

Jones D, Buttgereit T, Carne E, Cohn D

EAACI 2024

The complexities of decision-making associated with on-demand treatment of hereditary angioedema (HAE) attacks

Betschel SD, Caballero T, Jones DH, Longhurst HJ, Manning M, van Kooten S, Heckmann M, Danese S, Goga L, Burnette AF
Allergy, Asthma & Clinical Immunology